Profile data is unavailable for this security.
About the company
Fleury SA is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The Company operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.
- Revenue in BRL (TTM)4.37bn
- Net income in BRL347.77m
- Incorporated1964
- Employees16.70k
- LocationFleury SAAv. General Valdomiro de Lima508, JabaquaraSAO PAULO 04.344-070BrazilBRA
- Phone+55 1 150351986
- Fax+55 1 150147425
- Websitehttp://www.fleury.com.br/
More ▼
Mergers & acquisitions
| Acquired company | FLRY3:SAO since announced | Transaction value |
|---|---|---|
| Methodos Laboratorio Analises Clinicas e Hematologia Ltda | -11.59% | 5.05m |
| Instituto Hermes Pardini SA | 10.26% | 485.11m |
Data delayed at least 15 minutes, as of Jan 31 2023 21:07 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centro de Imagem Diagnosticos SA | 1.09bn | -135.49m | 2.53bn | -- | -- | 2.35 | -- | 2.32 | -1.15 | -1.15 | 9.26 | 9.10 | 0.4172 | 63.31 | 4.62 | -- | -4.92 | 0.2191 | -6.49 | 0.273 | 30.55 | 26.77 | -11.80 | 0.4881 | 0.8377 | -0.0445 | 0.5235 | -- | 22.37 | 3.62 | 94.23 | -- | -0.9897 | -- |
| Instituto Hermes Pardini SA | 2.07bn | 171.23m | 2.72bn | 7.10k | 15.32 | 2.75 | 8.64 | 1.31 | 1.35 | 1.35 | 16.37 | 7.55 | 0.9181 | 27.17 | 4.84 | 291,411.40 | 7.62 | 9.83 | 10.65 | 13.07 | 27.49 | 29.72 | 8.30 | 10.51 | 0.9356 | 40.86 | 0.4185 | 32.09 | 32.92 | 17.16 | 68.79 | 15.75 | 24.53 | -- |
| Hospital Mater Dei Sa | 1.54bn | 111.14m | 3.52bn | 3.68k | 32.38 | 1.99 | 17.36 | 2.29 | 0.2845 | 0.2845 | 3.96 | 4.62 | 0.4201 | 23.19 | 3.61 | -- | 3.51 | -- | 3.94 | -- | 36.60 | -- | 8.35 | -- | 2.62 | 2.79 | 0.5363 | -- | 42.69 | -- | 99.49 | -- | -- | -- |
| Oncoclinicas do Brasil Srvcs Mdcs SA | 3.64bn | -9.56m | 3.93bn | -- | -- | 1.96 | 18.99 | 1.08 | -0.0193 | -0.0193 | 7.35 | 4.07 | 0.5945 | 25.31 | 3.98 | -- | 0.6461 | -- | 0.8946 | -- | 34.77 | -- | 1.09 | -- | 1.33 | 1.23 | 0.5397 | -- | 32.77 | -- | 70.62 | -- | -- | -- |
| Fleury SA | 4.37bn | 347.77m | 5.68bn | 16.70k | 14.27 | 2.59 | 7.20 | 1.30 | 1.08 | 1.08 | 13.62 | 5.97 | 0.6775 | 40.70 | 5.18 | 272,890.00 | 5.42 | 6.96 | 6.74 | 8.43 | 28.29 | 29.53 | 8.00 | 10.63 | 1.32 | 2.84 | 0.6519 | 75.72 | 30.32 | 13.06 | 36.18 | 8.87 | 17.57 | -4.79 |
| Diagnosticos da America SA | 12.52bn | -339.50m | 6.15bn | 18.14k | -- | 0.8352 | 7.83 | 0.4911 | -0.5898 | -0.5898 | 21.76 | 13.13 | 0.5757 | 22.24 | 4.26 | -- | -1.56 | 0.1711 | -2.06 | 0.2218 | 28.99 | 30.79 | -2.71 | 0.2926 | 1.13 | 0.8356 | 0.6309 | 1,170.85 | 48.01 | 27.93 | -50.24 | -- | 22.42 | 42.34 |
| Odontoprev SA | 1.87bn | 444.40m | 6.47bn | 2.03k | 14.45 | 5.22 | 12.73 | 3.45 | 0.7875 | 0.7875 | 3.32 | 2.18 | 0.9304 | 150.06 | 12.96 | -- | 22.00 | 21.67 | 33.40 | 30.70 | 61.42 | 60.29 | 23.65 | 21.48 | 0.8099 | -- | 0.0384 | 61.27 | 4.37 | 6.15 | 5.33 | 11.98 | 30.90 | 5.95 |
Data as of Jan 31 2023. Currency figures normalised to Fleury SA's reporting currency: Brazilian Real BRL
14.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Jan 2023 | 8.40m | 2.29% |
| Bram Bradesco Asset Management S/A DTVMas of 30 Sep 2022 | 7.75m | 2.11% |
| Handelsbanken Fonder ABas of 31 Dec 2022 | 7.10m | 1.93% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2022 | 6.77m | 1.85% |
| BlackRock Brasil Gestora de Investimentos Ltda.as of 05 Jan 2023 | 5.36m | 1.46% |
| APG Asset Management NVas of 31 Dec 2021 | 4.62m | 1.26% |
| Ita� Unibanco SAas of 05 Jan 2023 | 3.95m | 1.08% |
| RBC Global Asset Management (UK) Ltd.as of 30 Nov 2022 | 3.87m | 1.06% |
| BlackRock Fund Advisorsas of 04 Jan 2023 | 3.51m | 0.96% |
| Van Eck Associates Corp.as of 05 Jan 2023 | 3.29m | 0.90% |
More ▼
Data from 30 Sep 2022 - 26 Jan 2023Source: FactSet Research Systems Inc.
